Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 23, 2026
CRWL: Analyzing the +57% Run in GraniteShares 2x Long CRWD Daily ETF

CRWL: Analyzing the +57% Run in GraniteShares 2x Long CRWD Daily ETF

Key Takeaways

  • CRWL, the GraniteShares 2x Long CRWD Daily ETF, has gained roughly 57% over the past 30 days, amplifying a powerful rally in cybersecurity leader CrowdStrike.
  • The fund seeks 2x (200%) the daily return of CRWD, so positive daily compounding in a trending market can push multi-day gains beyond a simple two-times multiple.
  • CrowdStrike's record fiscal second-quarter results—$333 million in net new annual recurring revenue (ARR) and raised full-year guidance—were the primary catalyst.
  • Rising AI-driven cybersecurity demand, led by the Falcon Flex consumption model and AI Detection and Response, underpinned the move.
  • The leveraged, daily-reset structure makes CRWL a short-term tactical tool rather than a buy-and-hold investment.

CRWL Overview and Its Focused Exposure

CRWL is an actively managed exchange-traded fund from GraniteShares that aims for daily results equal to 2x (200%) of the daily percentage change in CrowdStrike Holdings, Inc. Instead of spreading holdings across many securities, the fund directs all exposure to a single stock through swaps, options, and direct purchases of the underlying shares. The portfolio remains non-diversified by design.

Because it tracks one company, CRWL lacks a standard sector breakdown—its risk profile ties directly to CrowdStrike, a cybersecurity provider whose Falcon platform covers endpoint security, cloud security, identity protection, and next-generation SIEM. This concentrated, leveraged approach explains the fund's sharp recent moves: even modest daily shifts in the underlying stock get multiplied, and sustained trends can compound further.

CRWL Price Performance Over the Past 30 Days and Quarter

Over the past 30 days, CRWL rose from a closing price near $60.27 to approximately $94.32, delivering a gain of roughly +57%. The advance came in a trending pattern rather than steady increments, with sharp single-day jumps following CrowdStrike's stronger-than-expected results and guidance.

Over the broader quarter, the increase looks even larger. From a close near $50 in late June, the fund has climbed roughly +86% over the trailing three months. The path included drawdowns in June and mid-August before a sharp rebound into September, highlighting both the volatility of the underlying stock and the amplification from 2x daily leverage.

Drivers Behind CRWL's Recent 30-Day Move

The main catalyst came from CrowdStrike's fiscal second-quarter 2027 earnings, released after the U.S. market close on August 26. The company posted total revenue of $1.47 billion, up 26% year over year, along with record net new ARR of $333 million that accelerated to 51% year-over-year growth. Ending ARR reached $5.84 billion, while free cash flow hit a quarterly record of $377 million, or 26% of revenue.

Management lifted its fiscal 2027 net new ARR growth guidance by 630 basis points to 34% year over year at the midpoint. Falcon Flex adoption accelerated, with ending ARR from Flex accounts exceeding $2.29 billion and growing 101% year over year. AI security momentum stood out as well, with AI Detection and Response (AIDR) ARR expanding quickly as enterprises sought better visibility into growing AI workloads. CrowdStrike shares rose roughly 13% after the report, and CRWL's 2x daily leverage turned that move—plus follow-through buying—into larger fund-level gains. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Broader Factors Behind the Quarter's Performance

The three-month trend reflects a wider shift toward AI infrastructure and cybersecurity spending as companies allocate resources to protect expanding AI environments. CrowdStrike has benefited from the "agentic era" narrative, with organizations deploying AI agents and consuming AI at the endpoint where the Falcon platform holds a strong position. Product launches around AI security, including AIDR and agent-protection offerings, added to investor confidence in ongoing growth.

The fund's leverage magnified this underlying strength. After a June pullback in CrowdStrike shares, the stock recovered through July and August and accelerated after the second-quarter report. Positive daily compounding in a rising market allowed CRWL's cumulative gain to exceed a simple two-times multiple of the underlying over the quarter, illustrating how path-dependent leveraged daily-reset products perform in trending conditions.

CRWL Outlook and Key Factors to Monitor

Looking ahead, CRWL's path will depend almost entirely on CrowdStrike's fundamentals and the broader cybersecurity spending climate. Key items to watch include continued momentum in net new ARR and Falcon Flex adoption, the monetization of AI security products such as AIDR, and the pace of enterprise budget growth for AI infrastructure protection. Macroeconomic conditions, especially interest rate expectations and technology-sector risk appetite, will also shape the underlying stock's valuation, which remains at a premium to peers.

Investors should keep in mind the structural risks of 2x daily leverage, including volatility drag in choppy markets and the potential for rapid losses in a sharp downturn. The fund suits short-term tactical positioning, and performance over periods longer than a single day can diverge materially from two-times the underlying's return. No price predictions are offered here; the balance of catalysts and risks will depend on CrowdStrike's execution and the durability of AI-driven cybersecurity demand.

AI Screener

In my own research process, Tickeron's AI Screener has become a useful resource for scanning securities with technical indicators, fundamentals, volatility metrics, price patterns, and AI-generated signals. It helps surface ideas more efficiently than manual chart reviews, which is particularly helpful when following fast-moving leveraged products like CRWL where timing and trend direction matter. I find it streamlines monitoring market conditions and comparing opportunities across the industry.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRWL

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for CRWL turns positive, indicating new upward trend

CRWL saw its Momentum Indicator move above the 0 level on September 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator turned positive. In 28 of the 29 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CRWL just turned positive on September 14, 2026. Looking at past instances where CRWL's MACD turned positive, the stock continued to rise in 20 of 21 cases over the following month. The odds of a continued upward trend are 90%.

CRWL moved above its 50-day moving average on September 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +34.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWL advanced for three days, in 118 of 125 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

CRWL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 88 of 92 cases where CRWL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for CRWL moved out of overbought territory on August 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator moved out of overbought territory. In 11 of the 11 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Industry description

The investment seeks daily investment results, before fees and expenses, of 2 times (200%) the daily percentage change of the common stock of CrowdStrike Holdings Inc (NASDAQ: CRWD). The fund is an actively managed exchange traded fund that attempts to replicate 2x (200%) the daily percentage change of the underlying stock by entering into financial instruments such as swaps and options on the underlying stock as well as directly purchasing the underlying stock. The fund is non-diversified.
View a ticker or compare two or three
CRWL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
GraniteShares ETF Trust30 Vesey Street, 9th FloorNew York
Phone
N/A
Web
N/A
Interact to see
Advertisement
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.